Biosimilars 2022 Year in Review | Fish & Richardson : compar

2022 heralded the next chapter for biosimilars in the United States, including U.S. Food and Drug Administration approval of biosimilars in new therapeutic areas, additional...

Related Keywords

Delaware , United States , Illinois , Pennsylvania , Poland , West Virginia , Polish , Americans , American , Thomas Edison , Genentech Herceptin , Mylan Eylea , Amgen Neulasta , Celltrion Teva , Samsung Bioepis , Manish Shah , Katherine Vidal , Amgen Repatha , Genentech Avastin , Amgen , Genentech , Boehringer Ingelheim , Us District Court , Microsoft , Pfizer , Samsung , Trademark Office , Abbvie Inc , Qualcomm , Juno Therapeutics Inc , Intel , Kite Pharma Inc , Fees In Exchange , Illinois Abbvie Inc , City Council Of Baltimore , While The Supreme Court , Supreme Court , Law Division Of The American Chemical Society , District Court Litigation , Public Health Service , Amgen Inc , Johnson , Nrelated Cases , Northern District , Public Health Service Act , United States Patent , Federal Rule , Civil Procedure , Federal Rule Civil Procedure , Bevacizumab Settlement Agreement , Alvotech United States , Commercial Marketing , Alvotech United , Federal Rules , Declaratory Judgment Act , Federal Circuit , Judge Lourie , Judges Prost , Law Division , American Chemical Society , Juno Therapeutics , Patent Thickets , Seventh Circuit , Judge Manish Shah , Antitrust Litig , City Council , Vie Inc , President Biden , Anticompetitive Exclusionary , Remicade Antitrust Litigation , Fairness Hearing , Federal Trade Commission , Excluding Lower Cost Drug , Pharmacy Benefit Managers , Grant Challenges , Patent Trial ,